treatment group:Therapeutic lifestyle changes + Xuezhikang

2 trials

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Carotid atherosclerosisatherosclerosis

Phase 4

Exploring the Benefits of Xuezhikang in Achieving Lower LDL-C Levels for Primary Prevention in High-Risk ASCVD Populations and Its Impact on the Development of Generalized Atherosclerosis

Active, not recruitingChiCTR2500101995

Ruijin Hospital, Shanghai Jiao Tong University School of Medicineatherosclerosis

Start: 2025-05-15Updated: 2025-05-12

Unknown Phase

Study on the effect and underlying mechanism of Xuezhikang on vulnerable carotid plaques in hypertensive populations based on contrast-enhanced ultrasound (CEUS) imaging

Active, not recruitingChiCTR2500100525

Ruijin Hospital, Shanghai Jiao Tong University School of MedicineCarotid atherosclerosis

Start: 2025-04-10Updated: 2025-04-14